NO813772L - Fremgangsmaate for bestemmelse av antistoffer. - Google Patents
Fremgangsmaate for bestemmelse av antistoffer.Info
- Publication number
- NO813772L NO813772L NO813772A NO813772A NO813772L NO 813772 L NO813772 L NO 813772L NO 813772 A NO813772 A NO 813772A NO 813772 A NO813772 A NO 813772A NO 813772 L NO813772 L NO 813772L
- Authority
- NO
- Norway
- Prior art keywords
- streptolysin
- oxidized
- sample
- stated
- reducing agent
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 23
- 239000003638 chemical reducing agent Substances 0.000 claims description 17
- 239000000523 sample Substances 0.000 claims description 16
- 210000003743 erythrocyte Anatomy 0.000 claims description 12
- 206010018910 Haemolysis Diseases 0.000 claims description 11
- 230000008588 hemolysis Effects 0.000 claims description 11
- 238000004458 analytical method Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 230000002949 hemolytic effect Effects 0.000 claims description 9
- 210000004369 blood Anatomy 0.000 claims description 8
- 239000008280 blood Substances 0.000 claims description 8
- 210000002966 serum Anatomy 0.000 claims description 8
- 239000013068 control sample Substances 0.000 claims description 7
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims description 6
- 239000003085 diluting agent Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 3
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims description 3
- 229960004308 acetylcysteine Drugs 0.000 claims description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 3
- 235000018417 cysteine Nutrition 0.000 claims description 3
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims description 3
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 claims description 3
- 238000004062 sedimentation Methods 0.000 claims description 3
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims description 3
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 3
- 235000010265 sodium sulphite Nutrition 0.000 claims description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- 238000005259 measurement Methods 0.000 claims description 2
- 238000009007 Diagnostic Kit Methods 0.000 claims 3
- 239000004296 sodium metabisulphite Substances 0.000 claims 2
- 239000000243 solution Substances 0.000 description 12
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 108010011834 Streptolysins Proteins 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 241001505901 Streptococcus sp. 'group A' Species 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 229940001482 sodium sulfite Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56944—Streptococcus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT21549/81A IT1218273B (it) | 1981-05-07 | 1981-05-07 | Metodo integrato per l'analisi degli anticorpi antistreptolisinici e mezzi adatti allo scopo |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO813772L true NO813772L (no) | 1982-11-08 |
Family
ID=11183447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO813772A NO813772L (no) | 1981-05-07 | 1981-11-09 | Fremgangsmaate for bestemmelse av antistoffer. |
Country Status (18)
| Country | Link |
|---|---|
| AR (1) | AR229167A1 (fi) |
| AU (1) | AU551120B2 (fi) |
| BE (1) | BE891075A (fi) |
| BR (1) | BR8107026A (fi) |
| CA (1) | CA1179258A (fi) |
| CH (1) | CH655801A5 (fi) |
| DE (1) | DE3144042A1 (fi) |
| DK (1) | DK470581A (fi) |
| ES (1) | ES507495A0 (fi) |
| FI (1) | FI813512L (fi) |
| FR (1) | FR2505502B1 (fi) |
| GB (1) | GB2098322B (fi) |
| GR (1) | GR76695B (fi) |
| IT (1) | IT1218273B (fi) |
| NO (1) | NO813772L (fi) |
| NZ (1) | NZ198700A (fi) |
| PT (1) | PT73958B (fi) |
| SE (1) | SE8106638L (fi) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR19262A (tr) * | 1975-12-22 | 1978-09-19 | Sclavo Inst Sieroterapeut | Antistreptolisin antikor'larin titrasyonu icin cihaz ve bu cihazin unsurlari vasitasiyle yapilan titrasyon usulu |
| IT1132167B (it) * | 1980-07-03 | 1986-06-25 | Diesse Diagnostica Senese Srl | Metodo emolitico per la determinazione in continuo degli anticorpi antistreptolisina o,in campioni di sangue o di siero con impiego di streptolisina o ossidata |
-
1981
- 1981-05-07 IT IT21549/81A patent/IT1218273B/it active
- 1981-10-20 NZ NZ198700A patent/NZ198700A/en unknown
- 1981-10-26 DK DK470581A patent/DK470581A/da not_active Application Discontinuation
- 1981-10-26 BR BR8107026A patent/BR8107026A/pt unknown
- 1981-10-26 GR GR66356A patent/GR76695B/el unknown
- 1981-11-02 AU AU77045/81A patent/AU551120B2/en not_active Ceased
- 1981-11-05 DE DE19813144042 patent/DE3144042A1/de not_active Withdrawn
- 1981-11-09 GB GB8133724A patent/GB2098322B/en not_active Expired
- 1981-11-09 FR FR8120974A patent/FR2505502B1/fr not_active Expired
- 1981-11-09 CA CA000389715A patent/CA1179258A/en not_active Expired
- 1981-11-09 AR AR287389A patent/AR229167A1/es active
- 1981-11-09 NO NO813772A patent/NO813772L/no unknown
- 1981-11-09 SE SE8106638A patent/SE8106638L/ unknown
- 1981-11-09 FI FI813512A patent/FI813512L/fi not_active Application Discontinuation
- 1981-11-10 PT PT73958A patent/PT73958B/pt unknown
- 1981-11-10 CH CH7224/81A patent/CH655801A5/it not_active IP Right Cessation
- 1981-11-10 ES ES507495A patent/ES507495A0/es active Granted
- 1981-11-10 BE BE0/206510A patent/BE891075A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB2098322A (en) | 1982-11-17 |
| CA1179258A (en) | 1984-12-11 |
| IT1218273B (it) | 1990-04-12 |
| SE8106638L (sv) | 1982-11-08 |
| ES8302310A1 (es) | 1982-12-16 |
| PT73958B (en) | 1983-11-23 |
| CH655801A5 (it) | 1986-05-15 |
| FR2505502A1 (fr) | 1982-11-12 |
| BE891075A (fr) | 1982-05-10 |
| AU7704581A (en) | 1982-11-11 |
| IT8121549A0 (it) | 1981-05-07 |
| FI813512L (fi) | 1982-11-08 |
| DK470581A (da) | 1982-11-08 |
| PT73958A (en) | 1981-12-01 |
| AU551120B2 (en) | 1986-04-17 |
| BR8107026A (pt) | 1983-04-12 |
| GB2098322B (en) | 1985-02-06 |
| ES507495A0 (es) | 1982-12-16 |
| AR229167A1 (es) | 1983-06-30 |
| GR76695B (fi) | 1984-08-24 |
| NZ198700A (en) | 1985-12-13 |
| DE3144042A1 (de) | 1982-11-25 |
| FR2505502B1 (fr) | 1985-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Francesconi et al. | Urinary and hematologic indexes of hypohydration | |
| Shields et al. | Determination of protein-bound carbohydrate in serum by modified anthrone method | |
| Macpherson | The basic amino-acid content of proteins | |
| Miettinen et al. | Calretinin is present in non-pyramidal cells of the rat hippocampus—II. Co-existence with other calcium binding proteins and GABA | |
| Hughes | The use of homocysteine in the estimation of dehydroascorbic acid | |
| Terjung et al. | Effect of running to exhaustion on skeletal muscle mitochondria: a biochemical study | |
| CA1091558A (en) | Blood control standard | |
| Crowlesmith et al. | Precursor Proteins Are Intermediates in vivo, in the Synthesis of Two Major Outer Membrane Proteins, the OmpA and OmpF Proteins, of Escherichia coli K12 | |
| EP0344287A4 (en) | Conservative whole blood sample preparation technique | |
| Riond et al. | Prevalence of dog erythrocyte antigen 1.1 in dogs in Switzerland evaluated with the gel column technique | |
| NO813772L (no) | Fremgangsmaate for bestemmelse av antistoffer. | |
| John-Alder | Reduced aerobic capacity and locomotory endurance in thyroid-deficient lizards | |
| Harvey | A fertility index derived from semen analysis | |
| Lambertsen et al. | Serum chemistry and evidence of renal failure in the North Atlantic fin whale population | |
| Irving et al. | Studies on l‐glutamate in insect haemolymph. III. Amino acid analyses of the haemolymph of various arthropods | |
| Tasman et al. | Determination of diphtheria and tetanus antitoxin with the aid of haemagglutination | |
| Gibson et al. | Modified Waaler-Rose reaction employing sensitized human cells | |
| US4148609A (en) | Method for measuring antistreptolysin concentration in blood | |
| Burley | The Estimation of Sulfhydryl Groups in Wool by Means of 1-(4-Chloromercuriphenylazo)-Naphthol-2: Part I: Experiments on Intact Fibers | |
| Marucci | MECHANISM OF ACTION OF STAPHYLOCOCCAL ALPHA-HEMOLYSIN II: Analysis of the Kinetic Curve and Inhibition by Specific Antibody | |
| CN105004866A (zh) | 快速检测食品中副溶血性弧菌tdh毒素的试剂盒及其应用 | |
| Ryan | An improved microdiffusion procedure for the determination of lactic acid | |
| CA3092425A1 (en) | Methods for the detection of autologous blood-doping | |
| RU2671636C1 (ru) | Способ неинвазивной оценки среднего уровня нейротрофического фактора мозга (bdnf) в плазме крови на основе показателей микроэлементного анализа волос | |
| Hammond et al. | A method for the detection of lead in bovine blood and liver |